Children's cancers, Neuroblastoma
Results
Phase 2/3
This trial looked at treatment for children and young people with a rare type of cancer called neuroblastoma that was high risk.
High risk means the cancer would continue to grow or come back (recur) after treatment.
Cancer Research UK supported this trial.
Recruitment start: 1 December 2002
Recruitment end: 8 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Elliot
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Cancer Research UK Children's Cancer Trials Team, University of Birmingham
This is Cancer Research UK trial number CRUK/02/013.
Last reviewed: 6 July 2022
CRUK internal database number: 239
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
